MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human CAS NO.118506-26-6

MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human CAS NO.118506-26-6

MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human CAS NO.118506-26-6

MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human CAS NO.118506-26-6

MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human CAS NO.118506-26-6

MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human is a high-purity synthetic peptide preparation containing two distinct but related sequences: the human and guinea pig variants of the MBP 87-99 encephalitogenic epitope. This product provides researchers with both species-specific sequences (VHFFKNIVTPRTP for human, VHFFKNIVTPHPQ for guinea pig) in a single preparation, enabling comparative studies of autoimmune epitope recognition and species-specific immune responses. Manufactured under stringent quality controls with HPLC-verified purity and comprehensive analytical documentation, this dual-sequence product serves as a critical tool for experimental autoimmune encephalomyelitis (EAE) model development, T cell epitope mapping, and multiple sclerosis research.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
MBP (87-99), human; Myelin Basic Protein (87-99), guinea pig, human
CAS NO.
118506-26-6
Appearance
White to off-white lyophilized powder
Molecular Formula
C74H114N20O17
Molecular Weight
 1555.86g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, PBS (pH 7-8), or an aqueous solution containing a small amount of DMSO.

Endotoxin< 1.0 EU/mg
Biological Activity
Autoimmune epitopes of myelin basic proteins; can induce experimental autoimmune encephalomyelitis (EAE), used for multiple sclerosis models, T-cell epitope and autoimmune research.
Storage Conditions
Store at -20°C or below, protected from light and moisture. After reconstitution, aliquot and store at -20°C
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

The MBP 87-99 peptide functions as a major encephalitogenic epitope that induces autoimmune responses through MHC class II presentation. Antigen-presenting cells (APCs) process and present the peptide via MHC class II molecules to CD4⁺ T helper cells. The specific interaction between the peptide-MHC complex and T cell receptors (TCRs) activates autoreactive T cells, leading to their proliferation and differentiation into Th1 or Th17 effector cells. These activated T cells migrate across the blood-brain barrier, recognize myelin basic protein in the central nervous system, and initiate an inflammatory cascade involving cytokine release, macrophage activation, and demyelination. The guinea pig sequence (VHFFKNIVTPHPQ) is particularly potent in inducing EAE in susceptible animal strains due to its high affinity for certain MHC class II molecules, while the human sequence (VHFFKNIVTPRTP) allows for comparative studies of human autoimmune responses.


2.PRODUCT INDICATIONS

EAE Model Development: Induction of experimental autoimmune encephalomyelitis in susceptible animal models
Multiple Sclerosis Research: Study of autoimmune demyelination mechanisms and neuroinflammation
T Cell Epitope Mapping: Identification and characterization of autoreactive T cell epitopes
Species-Specific Immune Response: Comparative analysis of human vs. guinea pig epitope recognition
Autoimmune T Cell Activation: Investigation of T cell activation, proliferation, and cytokine production
Immunotherapy Development: Screening and evaluation of therapeutic interventions for autoimmune diseases


3.CLINICAL EFFICACY OF PRODUCT

Sequence Authenticity: Verified VHFFKNIVTPRTP (human) and VHFFKNIVTPHPQ (guinea pig) sequences
Biological Activity: Validated in EAE induction models, T cell proliferation assays, and MHC binding studies
Species-Specific Potency: Confirmed differential encephalitogenic activity between human and guinea pig sequences
Research Reproducibility: Consistent performance in autoimmune disease models and immunological assays


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.